Invention Grant
- Patent Title: Engineered CRISPR-Cas9 nucleases
-
Application No.: US15249756Application Date: 2016-08-29
-
Publication No.: US09926546B2Publication Date: 2018-03-27
- Inventor: J. Keith Joung , Benjamin Kleinstiver , Vikram Pattanayak
- Applicant: The General Hospital Corporation
- Applicant Address: US MA Boston
- Assignee: The General Hospital Corporation
- Current Assignee: The General Hospital Corporation
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- Main IPC: C12N9/16
- IPC: C12N9/16 ; C12N9/22 ; C12N15/90
Abstract:
Engineered CRISPR-Cas9 nucleases with improved specificity and their use in genomic engineering, epigenomic engineering, genome targeting, and genome editing.
Public/Granted literature
- US20170058271A1 Engineered CRISPR-Cas9 Nucleases Public/Granted day:2017-03-02
Information query
